This is the authors' abstract. We don't add key points for this paper.
The development of efficient and stable therapeutic platforms for achieving broad‐spectrum antibacterial photodynamic therapy (aPDT) remains a critical challenge in combating microbial resistance. Herein, through three cascaded molecular engineering steps, a hyperbranched polymer based covalently linked micelle is developed to show highly broad‐spectrum aPDT efficacy. First, through precise molecular structural optimization, a conjugated hyperbranched polymer photosensitizer TSeHP with far‐red/near‐infrared emission and high reactive oxygen species (ROS) generation efficiency is developed and synthesized from an AB 2 ‐type monomer, which is also featured with large number of terminal alkyne groups in its periphery. Subsequently, through azide‐alkyne click chemistry reaction, TSeHP is decorated with polyethylene glycol (PEG) to form covalently linked micelles TSeHP‐PEG with much better stability during biomedical applications, as compared to conventional micelles or nanoparticles. Finally, to further confer targeting capability and inherent antibacterial properties, TSeHP‐PEG is covalently conjugated with a hydrophilic antimicrobial peptide, yielding TSeHP‐P with good biocompatibility. Microbiological assays demonstrate that TSeHP‐P enables real‐time imaging and exhibits potent broad‐spectrum antibacterial photodynamic activity against pathogens, including methicillin‐resistant Staphylococcus aureus (MRSA), via membrane disruption. Moreover, TSeHP‐P demonstrates excellent performance in accelerating the healing process of MRSA‐infected wounds in rats, showing good potential in infective therapeutic applications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: